Zinc phthalocyanine

CAS No. 14320-04-8

Zinc phthalocyanine( ZnPc )

Catalog No. M20539 CAS No. 14320-04-8

Zinc phthalocyanine are photosensitiveis commonly applied in industry (catalysts photoconductors) and biomedical (photodynamic therapy).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG 27 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Zinc phthalocyanine
  • Note
    Research use only, not for human use.
  • Brief Description
    Zinc phthalocyanine are photosensitiveis commonly applied in industry (catalysts photoconductors) and biomedical (photodynamic therapy).
  • Description
    Zinc phthalocyanine are photosensitiveis commonly applied in industry (catalysts photoconductors) and biomedical (photodynamic therapy).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ZnPc
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    14320-04-8
  • Formula Weight
    577.9
  • Molecular Formula
    C32H16N8Zn
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMF : 2.7 mg/mL (4.67 mM)
  • SMILES
    N=4c2c1ccccc1c3N=C%10N=C(N=C8N([Zn]n23)C(=NC5=NC=4c6ccccc56)c7ccccc78)c9ccccc9%10
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Neuropeptide Y (18-3...

    Neuropeptide Y (18-36) (porcine) is a competitive neuropeptide Y (NPY) cardiac receptor antagonist. Neuropeptide Y (18-36) (porcine) inhibits the binding of I-NPY to cardiac ventricular membranes in a concentration-dependent manner with an IC50 value of 158 nM and an Ki value of 140 nM. Neuropeptide Y (18-36) (porcine) can be used for the research of congestive heart failure.

  • Astragenol

    Astragenol is an intermediate used for Astragenol derivative synthesis. Astragenol derivatives are promising anti-inflammatory agents for prostate cancer research.

  • Allatostatin VII

    Allatostatin VII